Taro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TAROFree Report) in a research note issued to investors on Tuesday. The brokerage issued a strong-buy rating on the stock.

Taro Pharmaceutical Industries Trading Up 0.4 %

Taro Pharmaceutical Industries stock opened at $42.58 on Tuesday. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of 34.90 and a beta of 0.60. The company’s 50-day moving average price is $42.26 and its two-hundred day moving average price is $41.05. Taro Pharmaceutical Industries has a 52 week low of $28.10 and a 52 week high of $45.76.

Hedge Funds Weigh In On Taro Pharmaceutical Industries

Large investors have recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC acquired a new position in shares of Taro Pharmaceutical Industries in the 3rd quarter worth approximately $65,000. LRI Investments LLC acquired a new position in shares of Taro Pharmaceutical Industries in the 1st quarter worth approximately $84,000. PenderFund Capital Management Ltd. acquired a new position in shares of Taro Pharmaceutical Industries in the 4th quarter worth approximately $92,000. Strs Ohio grew its stake in shares of Taro Pharmaceutical Industries by 58.8% in the 3rd quarter. Strs Ohio now owns 2,700 shares of the company’s stock worth $101,000 after purchasing an additional 1,000 shares during the last quarter. Finally, FNY Investment Advisers LLC acquired a new position in shares of Taro Pharmaceutical Industries in the 4th quarter worth approximately $105,000. Institutional investors and hedge funds own 91.40% of the company’s stock.

About Taro Pharmaceutical Industries

(Get Free Report)

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.

Featured Articles

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.